Delivery Order SPE2DB20D3304-SPE2DB25FW7V8
Award Date 7/8/25
Potential Completion Date 7/9/25
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $2,339.04 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,685,145 units of the drug Fluticasone Prop HFA 110 MCG 12GM. This contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This is a $3,971.80 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a prescription medication, with a performance period ending on July 10, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,073,385 units of the prescription drug Fluticasone Prop HFA 110 MCG 12GM. The award has a total ceiling value of $11,982.82 and a period of performance through April 30, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA, valued at $999,999,999.00,...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,564,184,313 units of Fluticasone Prop HFA 110 MCG 12GM. The $3,843.09 firm-fixed-price contract has an ultimate completion date of April 8, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range...
- This is a $2,342.41 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The order is for the supply of 4,565,434,235 units of Fluticasone Prop HFA 110 MCG 12GM, a prescription pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, which enables the agency to efficiently procure a comprehensive range...
- This is a $1,864.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Fluticasone Propionate HFA 110 mcg 12 g inhalers. The contract has an ultimate completion date of August 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- This is a $2,007.81 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Fluticasone Prop HFA 220 MCG 12GM, a prescription medication. The contract has an ultimate completion date of August 2, 2024 and was awarded on August 1, 2024. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,298.08, is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through May 23, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,740.46, is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to support military healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,388.97 firm-fixed-price contract is for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a prescription medication. The order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB25FW7V8Delivery Order
This is a $1,043.86 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a prescription medication, with a period of performance through July 9, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA, which provides a comprehensive global pharmaceutical support vehicle for military and government healthcare programs through December 2026. The contract is not set aside and was awarded through open competition.
Generated 10/7/25, 9:49 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/8/25 |